2023
- Torrent and Zydus sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India
- Torrent Pharmaceuticals gets EIR from US FDA for Dahej facility
2022
- Agreement with Dr. Reddy's Laboratories Ltd. to acquire four of its brands "Styptovit-E", "Finast", "Finast-T", and "Dynapress"
- Torrent Pharma enters into licensing agreement with Medicine Patent Pool to manufacture and commercialise generic version of Pfizer Oral COVID-19 Treatment
- Enters into co-marketing partnership with Boehringer Ingelheim India Private Limited to co- market its anti-diabetic drug and its fixed dose combinations in India
- Torrent Pharma acquires Curatio Healthcare to strengthen its presence in fast growing dermatology segment
2021
- Torrent Pharma introduces MSD (a trade name of Merck & Co., Inc, Kenilworth, NJ, USA) and Ridgeback’s molnupiravir under the brand name Molnutor® in India
- Torrent Pharma Enters Into Voluntary Licensing Agreement with Lilly to manufacture and distribute Baricitinib for Covid-19 in India
2019
Torrent & Glenmark sign licensing agreement for co-marketing of Remogliflozin Etabonate in India
2018
Acquired US based Bio-Pharm, Inc. (BPI)
2017
Acquired US based Bio-Pharm, Inc. (BPI)
2016
- Dahej Plant receives USFDA approval
- Acquired API manufacturing Unit of Hyderabad based Glochem Industries Limited